Source: Eur Respir J 2009; 34: 694
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Ferland A., Poirier P., Series F.. Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients. Eur Respir J 2009; 34: 694

Member's Comments

No comment yet.

Related content which might interest you: Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003 The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Cardiac sympathovagal balance during sleep in obstructive sleep apnea patients is different under auto-adjusting CPAP than fixed-CPAP treatment Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Compliance with continuous positive airway pressure in patients with sleep apnea/hypopnea syndrome Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients Source: Eur Respir J 2006; 27: 1229-1235 Year: 2006 Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep Source: Eur Respir Rev 2007; 16: 115-124 Year: 2007 CPAP and measures of cardiovascular risk in males with OSAS Source: Eur Respir J 2008; 32: 1488-1496 Year: 2008 Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients Source: Eur Respir J 2004; 23: 255-262 Year: 2004 Blood pressure responsiveness to obstructive events during sleep after chronic CPAP Source: Eur Respir J 2003; 21: 509-514 Year: 2003 Continuous positive airway pressure treatment in patients with OSA Source: Eur Respir Mon 2010; 50: 244-266 Year: 2010 Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients Source: Eur Respir J 2004; 23: 891-895 Year: 2004 Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke Source: Eur Respir J 2001; 18: 623-629 Year: 2001 Obstructive sleep apnea Source: Respipedia Article Year: 2017 Residual sleep-disordered breathing during autotitrating continuous positive airway pressure therapy Source: Eur Respir J 2012; 39: 1391-1397 Year: 2012 Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 Recent weight history in patients with obstructive sleep apnea syndrome (OSAS) prior to continuous positive airway pressure (CPAP) therapy Source: Eur Respir J 2006; 28: Suppl. 50, 648s Year: 2006